Skip to main content

Table 6 Risks (incidence rate ratio) of infant mortality and hospital admission in PREGACT study

From: Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study

  IRR 95% CI p-value
Infant mortality
 AL 1 0.96
 ASAQ 0.96 0.44–2.09  
 MQAS 0.94 0.47–1.86  
 DHAPQ 1.12 0.57–2.20  
 Congenital anaemia 2.93 0.96–8.96 0.06
 Low birth weight 1.78 1.03–3.06 0.04
 Birth asphyxia 10.89 4.48–26.46 < 0.01
 Congenital abnormality 25.47 10.46–62.02 < 0.01
 Burkina Faso 1 < 0.01
 Ghana 1.02 0.31–3.36  
 Malawi 2.14 0.89–5.15  
 Zambia 4.02 1.85–8.73  
Hospital admission
 AL 1 0.91
 ASAQ 1.01 0.71–1.43  
 MQAS 0.88 0.57–1.35  
 DHAPQ 1.01 0.70–1.47  
 Baby ITN use 0.36 0.21–0.62 < 0.01
 Born at home 1.44 1.02–2.03 0.04
 Congenital malaria 3.80 0.93–15.56 0.06
 Congenital abnormality 5.12 2.09–12.51 < 0.01
 Burkina Faso 1 < 0.01
 Ghana 1.02 0.68–1.54  
 Malawi 1.89 1.33–2.69  
 Zambia 0.49 0.31–0.79  
  1. IRR incidence rate ratio